November 27, 2019

Bloomberg: MiMedx Indictments Could Mean the Worst Is Over

According to prosecutors, MiMedx reported revenue of $187.3 million in 2015. The alleged fraudulent activity accounted for just $9.5 million of that amount. One suspects that the earnings restatement, when it is finally completed, will mollify investors rather than alarm them. (via Bloomberg)

More News

September 7, 2023

Prescience Point Capital Management Reiterates “Strong Buy” Recommendation on AerSale Corporation with Price Target of $45.90

FAA Approval and Commercialization of AerAware, and Reacceleration of Growth in Core Business are Powerful Catalysts for Immediate Share Price Appreciation Recent, Large Insider Purchases…
May 31, 2022

Prescience Point Capital Management Releases Presentation Detailing Board And Management Failures at MiMedx Group
May 6, 2022

Prescience Point To WITHHOLD Votes for MiMedx Directors and Vote AGAINST the Advisory Approval of Executive Compensation

BATON ROUGE, La., May 6, 2022 —  Prescience Point Capital Management LLC (“Prescience Point”), a research-focused, catalyst-driven investment firm that beneficially owns approximately 6.7% of…
November 15, 2018

Institutional Investor Magazine Profiles Eiad Asbahi

Institutional Investor Magazine sat down with our founder Eiad Asbahi for a wide ranging profile on the firm’s strategy, history and latest short idea (Link…
See More News

Get our latest Reports delivered to your inbox

Company

Research

News

About

Contact

Legal

Privacy Policy

Disclaimer

© 2024 Prescience Point Capital Management. All rights reserved. Site by North Street.

Prescience Investment Group, LLC is a Registered Investment Advisor with the State of Louisiana and is not currently required to register in any other state. Prescience Investment Group, LLC may only conduct advisory business in those states in which it is registered as an investment adviser or qualifies for a corresponding exemption or exclusion from registration requirements.